The human ADFP gene is a direct liver-X-receptor (LXR) target gene and differentially regulated by synthetic LXR ligands

Molecular Pharmacology

Volumn 77, Issue 1, 2010, Pages 79-86

  Kotokorpi, Pia ^a   Venteclef, Nicolas ^a   Ellis, Ewa ^b,d   Gustafsson, Jan Åke ^a,c   Mode, Agneta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c University of Houston   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ACTIVATING TRANSCRIPTION FACTOR 4; ADIPOPHILIN; CELL NUCLEUS RECEPTOR; CYCLIC AMP; LIGAND; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; LUCIFERASE; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; PARTIAL AGONIST; PROTEIN P300; RNA POLYMERASE II;

3' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; DNA RESPONSIVE ELEMENT; GENE CONTROL; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR BINDING; TRANSCRIPTION REGULATION;

GENE EXPRESSION REGULATION; HUMANS; LIGANDS; MEMBRANE PROTEINS; ORPHAN NUCLEAR RECEPTORS; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; RNA POLYMERASE II; TRANSCRIPTION, GENETIC;

EID: 73549110874     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.059063     Document Type: Article

References (40)

1. Albers M, Blume B, Schlueter T, Wright MB, Kober I, Kremoser C, Deuschle U, and Koegl M (2006) A novel principle for partial agonism of liver X receptor ligands. Competitive recruitment of activators and repressors. J Biol Chem 281:4920-4930.
2. Antonio V, Janvier B, Brouillet A, Andreani M, and Raymondjean M (2003) Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells. Biochem J 376:351-360.
3. Batzer MA and Deininger PL (2002) Alu repeats and human genomic diversity. Nat Rev Genet 3:370-379.
4. Brasaemle DL, Barber T, Wolins NE, Serrero G, Blanchette-Mackie EJ, and Londos C (1997) Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J Lipid Res 38:2249-2263.
5. Chang BH, Li L, Paul A, Taniguchi S, Nannegari V, Heird WC, and Chan L (2006) Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein. Mol Cell Biol 26:1063-1076.
6. Chawla A, Lee CH, Barak Y, He W, Rosenfeld J, Liao D, Han J, Kang H, and Evans RM (2003) PPARdelta is a very low-density lipoprotein sensor in macrophages. Proc Natl Acad Sci U S A 100:1268-1273.
7. Collins JL, Fivush AM, Watson MA, Galardi CM, Lewis MC, Moore LB, Parks DJ, Wilson JG, Tippin TK, Binz JG, et al. (2002) Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J Med Chem 45:1963-1966.
8. Dalen KT, Ulven SM, Arntsen BM, Solaas K, and Nebb HI (2006) PPARalpha activators and fasting induce the expression of adipose differentiation-related protein in liver. J Lipid Res 47:931-943.
9. Farnegardh M, Bonn T, Sun S, Ljunggren J, Ahola H, Wilhelmsson A, Gustafsson JA, and Carlquist M (2003) The three-dimensional structure of the liver X receptor beta reveals a flexible ligand-binding pocket that can accommodate fundamentally different ligands. J Biol Chem 278:38821-38828.
10. Grefhorst A, Elzinga BM, Voshol PJ, Plosch T, Kok T, Bloks VW, van der Sluijs FH, Havekes LM, Romijn JA, Verkade HJ, et al. (2002) Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J Biol Chem 277:34182-34190.
11. Groot PH, Pearce NJ, Yates JW, Stocker C, Sauermelch C, Doe CP, Willette RN, Olzinski A, Peters T, d'Epagnier D, et al. (2005) Synthetic LXR agonists increase LDL in CETP species. J Lipid Res 46:2182-2191.
12. Houck KA, Borchert KM, Hepler CD, Thomas JS, Bramlett KS, Michael LF, and Burris TP (2004) T0901317 is a dual LXR/FXR agonist. Mol Genet Metab 83:184-187.
13. Imamura M, Inoguchi T, Ikuyama S, Taniguchi S, Kobayashi K, Nakashima N, and Nawata H (2002) ADRP stimulates lipid accumulation and lipid droplet formation in murine fibroblasts. Am J Physiol Endocrinol Metab 283:E775-E783.
14. Jakobsson T, Venteclef N, Toresson G, Damdimopoulos AE, Ehrlund A, Lou X, Sanyal S, Steffensen KR, Gustafsson JA, and Treuter E (2009) GPS2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus. Mol Cell 34:510-518.
15. Joseph SB and Tontonoz P (2003) LXRs: new therapeutic targets in atherosclerosis? Curr Opin Pharmacol 3:192-197.
16. Kase ET, Andersen B, Nebb HI, Rustan AC, and Thoresen GH (2006) 22-Hydroxycholesterols regulate lipid metabolism differently than T0901317 in human myotubes. Biochim Biophys Acta 1761:1515-1522.
17. Kotokorpi P, Ellis E, Parini P, Nilsson LM, Strom S, Steffensen KR, Gustafsson JA, and Mode A (2007) Physiological differences between human and rat primary hepatocytes in response to liver X receptor activation by 3-[3-[N-(2-chloro-3-trifluoromethylbenzyl)-(2,2-diphenylethyl)amino]propyl oxy]phenylacetic acid hydrochloride (GW3965). Mol Pharmacol 72:947-955.
18. Laffitte BA, Joseph SB, Walczak R, Pei L, Wilpitz DC, Collins JL, and Tontonoz P (2001) Autoregulation of the human liver X receptor alpha promoter. Mol Cell Biol 21:7558-7568.
19. Landis MS, Patel HV, and Capone JP (2002) Oxysterol activators of liver X receptor and 9-cis-retinoic acid promote sequential steps in the synthesis and secretion of tumor necrosis factor-alpha from human monocytes. J Biol Chem 277:4713-4721.
20. Li Y, Bolten C, Bhat BG, Woodring-Dietz J, Li S, Prayaga SK, Xia C, and Lala DS (2002) Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism. Mol Endocrinol 16:506-514.
21. Londos C, Brasaemle DL, Schultz CJ, Segrest JP, and Kimmel AR (1999) Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin Cell Dev Biol 10:51-58.
22. Magnusson B, Asp L, Bostrom P, Ruiz M, Stillemark-Billton P, Linden D, Boren J, and Olofsson SO (2006) Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very low-density lipoproteins. Arterioscler Thromb Vasc Biol 26:1566-1571.
23. Makishima M (2005) Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors. J Pharmacol Sci 97:177-183.
24. Marathe C, Bradley MN, Hong C, Lopez F, Ruiz de Galarreta CM, Tontonoz P, and Castrillo A (2006) The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages. J Biol Chem 281:32197-32206.
25. Martin S and Parton RG (2006) Lipid droplets: a unified view of a dynamic organelle. Nat Rev Mol Cell Biol 7:373-378.
26. Miao B, Zondlo S, Gibbs S, Cromley D, Hosagrahara VP, Kirchgessner TG, Billheimer J, and Mukherjee R (2004) Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. J Lipid Res 45:1410-1417.
27. Michael LF, Schkeryantz JM, and Burris TP (2005) The pharmacology of LXR. Mini Rev Med Chem 5:729-740.
28. Mitro N, Vargas L, Romeo R, Koder A, and Saez E (2007) T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR. FEBS Lett 581:1721-1726.
29. Olofsson SO, Bostrom P, Andersson L, Rutberg M, Perman J, and Boren J (2009) Lipid droplets as dynamic organelles connecting storage and efflux of lipids. Biochim Biophys Acta 1791:448-458.
30. Phelan CA, Weaver JM, Steger DJ, Joshi S, Maslany JT, Collins JL, Zuercher WJ, Willson TM, Walker M, Jaye M, et al. (2008) Selective partial agonism of liver X receptor alpha is related to differential corepressor recruitment. Mol Endocrinol 22:2241-2249.
31. Sandelin A and Wasserman WW (2005) Prediction of nuclear hormone receptor response elements. Mol Endocrinol 19:595-606.
32. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, et al. (2000) Role of LXRs in control of lipogenesis. Genes Dev 14:2831-2838.
33. Shang Y and Brown M (2002) Molecular determinants for the tissue specificity of SERMs. Science 295:2465-2468.
34. Strom SC, Pisarov LA, Dorko K, Thompson MT, Schuetz JD, and Schuetz EG (1996) Use of human hepatocytes to study P450 gene induction. Methods Enzymol 272: 388-401.
35. Targett-Adams P, McElwee MJ, Ehrenborg E, Gustafsson MC, Palmer CN and McLauchlan J (2005) A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. Biochim Biophys Acta 1728(1-2):95-104.
36. Tobin KA, Harsem NK, Dalen KT, Staff AC, Nebb HI, and Duttaroy AK (2006) Regulation of ADRP expression by long-chain polyunsaturated fatty acids in BeWo cells, a human placental choriocarcinoma cell line. J Lipid Res 47:815-823.
37. Varela GM, Antwi DA, Dhir R, Yin X, Singhal NS, Graham MJ, Crooke RM, and Ahima RS (2008) Inhibition of ADRP prevents diet-induced insulin resistance. Am J Physiol Gastrointest Liver Physiol 295:G621-G628.
38. Varga G and Su C (2007) Classification and predictive modeling of liver X receptor response elements. BioDrugs 21:117-124.
39. Wang Y, Rogers PM, Su C, Varga G, Stayrook KR, and Burris TP (2008) Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha. J Biol Chem 283: 26332-26339.
40. Wei P, Taniguchi S, Sakai Y, Imamura M, Inoguchi T, Nawata H, Oda S, Nakabeppu Y, Nishimura J, and Ikuyama S (2005) Expression of adipose differentiation-related protein (ADRP) is conjointly regulated by PU. 1 and AP-1 in macrophages. J Biochem 138:399-412.